1212862-77-5 Usage
Molecular structure
A phenyl ring with a trifluoromethyl group and a methyl group attached to it, connected to an ethylamine group.
Classification
An amine, a derivative of ammonia with a nitrogen atom bonded to one or more alkyl or aryl groups.
Functional groups
Phenyl ring, trifluoromethyl group, methyl group, and ethylamine group.
Chemical properties
As an amine, it can participate in reactions such as alkylation, acylation, and nucleophilic substitution.
Biological properties
Potentially useful in medicinal chemistry or in the synthesis of other organic compounds due to its unique chemical structure.
Applications
Used in various fields such as pharmaceuticals, dyes, and pesticides.
Reactivity
Can form salts with acids, and can act as a base due to the presence of the nitrogen atom.
Solubility
Generally soluble in organic solvents like ethanol and methanol, and may have limited solubility in water.
Stability
Stable under normal conditions, but sensitive to strong acids and bases.
Hazards
May have potential health risks, and proper handling and storage are necessary to minimize exposure.
Check Digit Verification of cas no
The CAS Registry Mumber 1212862-77-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,2,8,6 and 2 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1212862-77:
(9*1)+(8*2)+(7*1)+(6*2)+(5*8)+(4*6)+(3*2)+(2*7)+(1*7)=135
135 % 10 = 5
So 1212862-77-5 is a valid CAS Registry Number.
1212862-77-5Relevant articles and documents
SOS1 INHIBITORS
-
, (2022/02/09)
The present invention relates to compounds that inhibit Son of sevenless homolog 1 (SOS1) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.
SOS1 INHIBITORS
-
, (2021/09/04)
The present invention relates to compounds that inhibit Son of sevenless homolog 1 (SOS1) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the com
